252 related articles for article (PubMed ID: 32397656)
1. Antimetastatic Effects of Sesamin on Human Head and Neck Squamous Cell Carcinoma through Regulation of Matrix Metalloproteinase-2.
Chen JM; Chen PY; Lin CC; Hsieh MC; Lin JT
Molecules; 2020 May; 25(9):. PubMed ID: 32397656
[TBL] [Abstract][Full Text] [Related]
2. Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway.
Wu TK; Ou YC; Chen YP; Huang FM; Pan YR; Lee CJ
Anticancer Res; 2021 Aug; 41(8):3789-3799. PubMed ID: 34281838
[TBL] [Abstract][Full Text] [Related]
3. Epiberberine suppresses the metastasis of head and neck squamous cell carcinoma cells by regulating the MMP-13 and JNK pathway.
Ho HY; Chen MK; Lin CC; Lo YS; Chuang YC; Hsieh MJ
J Cell Mol Med; 2023 Dec; 27(23):3796-3804. PubMed ID: 37710409
[TBL] [Abstract][Full Text] [Related]
4. 4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways.
Yu FS; Lin ML; Hsu SC; Yu CC; Huang YP; Kuo YH; Chung JG
Int J Oncol; 2016 Aug; 49(2):579-88. PubMed ID: 27221634
[TBL] [Abstract][Full Text] [Related]
5. Sesamin protects SH-SY5Y cells against mechanical stretch injury and promoting cell survival.
Xu Z; Liu Y; Yang D; Yuan F; Ding J; Chen H; Tian H
BMC Neurosci; 2017 Aug; 18(1):57. PubMed ID: 28784087
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Lin FY; Hsieh YH; Yang SF; Chen CT; Tang CH; Chou MY; Chuang YT; Lin CW; Chen MK
J Oral Pathol Med; 2015 Oct; 44(9):699-706. PubMed ID: 25401496
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
8. Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells.
Lee CC; Liu KJ; Wu YC; Lin SJ; Chang CC; Huang TS
Inflammation; 2011 Jun; 34(3):209-21. PubMed ID: 20617373
[TBL] [Abstract][Full Text] [Related]
9. Sesamin inhibits lipopolysaccharide-induced inflammation and extracellular matrix catabolism in rat intervertebral disc.
Li K; Li Y; Xu B; Mao L; Zhao J
Connect Tissue Res; 2016 Sep; 57(5):347-59. PubMed ID: 27128308
[TBL] [Abstract][Full Text] [Related]
10. Campothecin suppresses cell proliferation and migration in head and neck squamous cell carcinoma by blocking RAB27A-mediated phosphatidylinositol 3 kinase (PI3K)/protein kinase B (AKT) pathway.
Zhao Y; Wang Y; Zhao L; Qu L; Zheng JH
J Physiol Pharmacol; 2024 Apr; 75(2):205-213. PubMed ID: 38736267
[TBL] [Abstract][Full Text] [Related]
11. Sesamin suppresses activation of microglia and p44/42 MAPK pathway, which confers neuroprotection in rat intracerebral hemorrhage.
Ohnishi M; Monda A; Takemoto R; Matsuoka Y; Kitamura C; Ohashi K; Shibuya H; Inoue A
Neuroscience; 2013 Mar; 232():45-52. PubMed ID: 23228810
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of invasion and migration by newly synthesized quinazolinone MJ-29 in human oral cancer CAL 27 cells through suppression of MMP-2/9 expression and combined down-regulation of MAPK and AKT signaling.
Lu CC; Yang JS; Chiang JH; Hour MJ; Amagaya S; Lu KW; Lin JP; Tang NY; Lee TH; Chung JG
Anticancer Res; 2012 Jul; 32(7):2895-903. PubMed ID: 22753753
[TBL] [Abstract][Full Text] [Related]
13. Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma.
Aroui S; Aouey B; Chtourou Y; Meunier AC; Fetoui H; Kenani A
Chem Biol Interact; 2016 Jan; 244():195-203. PubMed ID: 26721195
[TBL] [Abstract][Full Text] [Related]
14. Pinostilbene Hydrate Suppresses Human Oral Cancer Cell Metastasis by Downregulation of Matrix Metalloproteinase-2 Through the Mitogen-Activated Protein Kinase Signaling Pathway.
Hsieh MJ; Chin MC; Lin CC; His YT; Lo YS; Chuang YC; Chen MK
Cell Physiol Biochem; 2018; 50(3):911-923. PubMed ID: 30355929
[TBL] [Abstract][Full Text] [Related]
15. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.
Chueh FS; Chen YY; Huang AC; Ho HC; Liao CL; Yang JS; Kuo CL; Chung JG
Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632
[TBL] [Abstract][Full Text] [Related]
16. Disruption of CADM1-dependent cell-cell adhesion in human oral squamous cell carcinoma cells results in tumor progression, possibly through an increase of MMP-2 and MMP-9 expression.
Obara N; Kyakumoto S; Yamaguchi S; Yamada H; Ishisaki A; Kamo M
J Oral Biosci; 2024 Mar; 66(1):151-159. PubMed ID: 38030062
[TBL] [Abstract][Full Text] [Related]
17. Sesamin induces cell cycle arrest and apoptosis through p38/C-Jun N-terminal kinase mitogen-activated protein kinase pathways in human colorectal cancer cells.
Wang X; Qiao J; Zou C; Zhao Y; Huang Y
Anticancer Drugs; 2021 Mar; 32(3):248-256. PubMed ID: 33534411
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
[TBL] [Abstract][Full Text] [Related]
19. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor.
Gorur A; Patiño M; Shi T; Corrales G; Takahashi H; Rangel R; Gleber-Netto FO; Pickering C; Myers JN; Cata JP
J Cell Physiol; 2021 Nov; 236(11):7698-7710. PubMed ID: 34038587
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
Yang Z; Liao J; Carter-Cooper BA; Lapidus RG; Cullen KJ; Dan H
BMC Cancer; 2019 May; 19(1):485. PubMed ID: 31118072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
